Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.

Rattanavipapong W, Koopitakkajorn T, Praditsitthikorn N, Mahasirimongkol S, Teerawattananon Y.

Epilepsia. 2013 Sep;54(9):1628-38. doi: 10.1111/epi.12325. Epub 2013 Jul 29.

2.

Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.

Tiamkao S, Jitpimolmard J, Sawanyawisuth K, Jitpimolmard S.

Int J Clin Pharm. 2013 Aug;35(4):608-12. doi: 10.1007/s11096-013-9777-9. Epub 2013 May 7.

PMID:
23649893
3.

HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.

Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Prabmechai N, Vannaprasaht S, Chumworathayi P, Chen P, Sritipsukho P.

Pain Pract. 2012 Mar;12(3):202-8. doi: 10.1111/j.1533-2500.2011.00479.x. Epub 2011 Jun 16.

PMID:
21676164
4.

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.

Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P, Khunarkornsiri U, Auvichayapat N, Pavakul K, Kulkantrakorn K, Choonhakarn C, Phonhiamhan S, Piyatrakul N, Aungaree T, Pongpakdee S, Yodnopaglaw P.

Epilepsia. 2010 May;51(5):926-30. doi: 10.1111/j.1528-1167.2010.02533.x. Epub 2010 Mar 19.

5.

Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.

Dong D, Sung C, Finkelstein EA.

Neurology. 2012 Sep 18;79(12):1259-67. doi: 10.1212/WNL.0b013e31826aac73. Epub 2012 Sep 5.

PMID:
22955130
6.

Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients.

Zhang Y, Wang J, Zhao LM, Peng W, Shen GQ, Xue L, Zheng XX, He XJ, Gong CY, Miao LY.

Eur J Clin Pharmacol. 2011 Sep;67(9):885-7. doi: 10.1007/s00228-011-1009-4. Epub 2011 Mar 19.

PMID:
21424386
7.
8.

Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.

Wu XT, Hu FY, An DM, Yan B, Jiang X, Kwan P, Stefan H, Zhou D.

Epilepsy Behav. 2010 Nov;19(3):405-8. doi: 10.1016/j.yebeh.2010.08.007. Epub 2010 Sep 15.

PMID:
20833111
9.

Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.

Hsiao YH, Hui RC, Wu T, Chang WC, Hsih MS, Yang CH, Ho HC, Chang YG, Chen MJ, Lin JY, Chen DP, Chang PY, Wu TL, Hung SI, Chung WH.

J Dermatol Sci. 2014 Feb;73(2):101-9. doi: 10.1016/j.jdermsci.2013.10.003. Epub 2013 Oct 22.

PMID:
24268988
10.

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.

Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, Kangwanshiratada O, Hirankarn N, Suphapeetiporn K, Shotelersuk V.

Epilepsia. 2008 Dec;49(12):2087-91. doi: 10.1111/j.1528-1167.2008.01719.x. Epub 2008 Jul 14. Erratum in: Epilepsia. 2009 Apr;50(4):971.

11.

Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.

Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC, Chu CY, Chen YT.

Pharmacogenomics. 2010 Mar;11(3):349-56. doi: 10.2217/pgs.09.162.

PMID:
20235791
12.

Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?

Shi YW, Min FL, Qin B, Zou X, Liu XR, Gao MM, Wang Q, Zhou JQ, Liao WP.

Basic Clin Pharmacol Toxicol. 2012 Jul;111(1):58-64. doi: 10.1111/j.1742-7843.2012.00868.x. Epub 2012 Mar 17.

13.

HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese.

Cheung YK, Cheng SH, Chan EJ, Lo SV, Ng MH, Kwan P.

Epilepsia. 2013 Jul;54(7):1307-14. doi: 10.1111/epi.12217. Epub 2013 May 20.

14.

HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population.

Niihara H, Kakamu T, Fujita Y, Kaneko S, Morita E.

J Dermatol. 2012 Jul;39(7):594-601. doi: 10.1111/j.1346-8138.2011.01457.x. Epub 2011 Dec 29.

PMID:
22211527
15.

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.

Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, Chucherd P, Konyoung P, Vannaprasaht S, Choonhakarn C, Pisuttimarn P, Sangviroon A, Tassaneeyakul W.

Pharmacogenet Genomics. 2009 Sep;19(9):704-9. doi: 10.1097/FPC.0b013e328330a3b8.

PMID:
19696695
16.

Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population.

Saokaew S, Tassaneeyakul W, Maenthaisong R, Chaiyakunapruk N.

PLoS One. 2014 Apr 14;9(4):e94294. doi: 10.1371/journal.pone.0094294. eCollection 2014.

17.

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY; Taiwan SJS Consortium.

N Engl J Med. 2011 Mar 24;364(12):1126-33. doi: 10.1056/NEJMoa1009717.

18.

Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.

Amstutz U, Shear NH, Rieder MJ, Hwang S, Fung V, Nakamura H, Connolly MB, Ito S, Carleton BC; CPNDS clinical recommendation group.

Epilepsia. 2014 Apr;55(4):496-506. doi: 10.1111/epi.12564. Epub 2014 Mar 5. Review.

19.

Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions.

Chen Z, Liew D, Kwan P.

PLoS One. 2014 May 7;9(5):e96990. doi: 10.1371/journal.pone.0096990. eCollection 2014.

20.

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.

Ko TM, Chung WH, Wei CY, Shih HY, Chen JK, Lin CH, Chen YT, Hung SI.

J Allergy Clin Immunol. 2011 Dec;128(6):1266-1276.e11. doi: 10.1016/j.jaci.2011.08.013. Epub 2011 Sep 14.

PMID:
21924464
Items per page

Supplemental Content

Write to the Help Desk